Titan PharmaceuticalsTTNP
13F holders, Q2 2026 (June 30)5holders −1
0new positions
1sold out
$0.75avg. 13F price*
At the end of Q2 2026, 5 institutions reported holding Titan Pharmaceuticals Inc. (TTNP) in their 13F filings, down 1 from Q1 2026. 0 opened new positions and 1 sold out. The largest holders were CoreCap Advisors, LLC ($65), Caldwell Sutter Capital, Inc. ($1) and St Germain D J Co. Inc. ($1).
- Company
- Titan Pharmaceuticals Inc.
- Filed as
- BLACK TITAN CORP ORD SHS (Q2 2026)
- CUSIP
- 888314705
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $3 |
All 13F filers, Q1 2026 → Q2 2026: 2 shares sold, net −2 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| CoreCap Advisors, LLC | 0.00% | No change | 88 | $65 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 1 | $1 |
| St Germain D J Co. Inc. | 0.00% | No change | 1 | $1 |
| Bogart Wealth, LLC | 0.00% | No change | 1 | $1 |
| Farther Finance Advisors, LLC | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is TTNP's weight in each manager's 13F, not the share of Titan Pharmaceuticals Inc. the manager owns.